ERBB2 and breast carcinoma: A series of breast cancer specific DNA aptamers against HER2-enriched SK-BR-3 (sk6Ea) and luminal A subtype MCF-7 cells (MF3/MF3Ec) were selected by Nongyue He et al.46-48.